As per Intent Market Research, the Interventional Imaging Market was valued at USD 14.1 Billion in 2024-e and will surpass USD 20.6 Billion by 2030; growing at a CAGR of 6.6% during 2025 - 2030.
The Interventional Imaging Market is a critical segment of the medical imaging industry, encompassing advanced imaging systems that aid in guiding minimally invasive surgical procedures. These imaging modalities play a vital role in improving precision, reducing complications, and enhancing patient outcomes. The market is experiencing growth due to the rising prevalence of chronic diseases, increasing demand for image-guided therapies, and continuous advancements in imaging technologies.
The integration of artificial intelligence (AI) and machine learning in imaging systems, along with innovations in portable and hybrid imaging solutions, are transforming the interventional imaging landscape. The expansion of healthcare infrastructure in emerging economies and the increasing preference for minimally invasive procedures further contribute to the market's development.
X-Ray Systems Lead the Market Owing to Versatility in Diagnostic and Interventional Applications
X-ray systems dominate the interventional imaging market, driven by their versatility and widespread application across multiple medical specialties. These systems are essential for real-time visualization of internal structures, enabling precise guidance during minimally invasive procedures such as angioplasty and orthopedic surgeries.
Recent advancements, such as digital X-ray systems and portable C-arm fluoroscopy units, have enhanced the efficiency and accuracy of X-ray imaging. Their cost-effectiveness and ease of integration into existing healthcare setups also contribute to their leadership in the market. The demand for X-ray systems is further bolstered by the increasing prevalence of cardiovascular diseases and trauma cases requiring interventional procedures.
Software Is Fastest-Growing Component Segment Due to Integration of Advanced Analytics
The software segment is the fastest-growing component category in the interventional imaging market, driven by the growing adoption of AI-powered tools and advanced image processing solutions. Modern software enhances image clarity, automates procedural workflows, and supports 3D visualization for complex interventions, such as neurological and cardiovascular surgeries.
Additionally, the rise of cloud-based solutions and interoperability features that enable seamless integration with hospital information systems (HIS) and electronic health records (EHR) are driving growth. With the increasing focus on precision medicine and real-time imaging analytics, the software segment is poised to expand further.
Cardiology Is Largest Application Segment Due to High Prevalence of Cardiovascular Diseases
Cardiology represents the largest application segment in the interventional imaging market, attributed to the high global burden of cardiovascular diseases (CVDs) such as coronary artery disease and stroke. Imaging systems like X-rays, CT, and fluoroscopy are critical in guiding interventions like stent placements and angioplasty, ensuring better procedural outcomes.
The growing adoption of hybrid imaging modalities, such as PET-CT and SPECT-CT, for cardiac imaging has further strengthened the segment's position. With the aging population and increasing prevalence of lifestyle-related risk factors, the demand for interventional imaging in cardiology is expected to remain robust.
Hospitals Dominate the End-Use Industry Due to High Procedure Volumes and Advanced Infrastructure
Hospitals are the largest end-use segment in the interventional imaging market, as they are the primary settings for complex interventional procedures across various specialties. Hospitals are equipped with advanced imaging systems and skilled personnel, making them ideal for performing image-guided interventions.
The increasing number of hospitals with dedicated interventional radiology units and government initiatives to upgrade healthcare infrastructure in emerging economies further support the segment's dominance. Additionally, the growing number of multi-specialty hospitals offering advanced cardiac, orthopedic, and oncology treatments contributes to the segment's leadership.
North America Leads the Market Due to Advanced Healthcare Infrastructure
North America is the largest regional market for interventional imaging, owing to its well-established healthcare infrastructure and high adoption of advanced imaging technologies. The region benefits from significant investments in R&D, a strong presence of leading market players, and a high prevalence of chronic diseases requiring interventional procedures.
The United States dominates the regional market, driven by its advanced hospital networks, government support for technological advancements, and the growing geriatric population. The increasing adoption of AI and machine learning in imaging systems further propels market growth in the region.
Competitive Landscape and Leading Companies
The Interventional Imaging Market is characterized by intense competition, with major players focusing on innovation and strategic collaborations. Key companies include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Fujifilm Holdings Corporation.
These companies are investing heavily in the development of hybrid and AI-enabled imaging systems to enhance precision and procedural efficiency. Collaborations with healthcare providers for customized solutions and market expansion into emerging economies are also shaping the competitive landscape. As the demand for minimally invasive interventions grows, leading players are expected to maintain their competitive edge through continuous advancements in imaging technology.
Recent Developments:
- Siemens Healthineers launched an AI-powered CT scanner for real-time interventional imaging.
- GE HealthCare introduced advanced ultrasound technology tailored for interventional radiology.
- Philips Healthcare unveiled a next-generation fluoroscopy system for precision-guided interventions.
- Canon Medical Systems announced the development of a compact MRI system for interventional use.
- Fujifilm expanded its ultrasound portfolio with advanced interventional imaging capabilities.
List of Leading Companies:
- Siemens Healthineers
- GE HealthCare
- Philips Healthcare
- Canon Medical Systems Corporation
- Hitachi Medical Systems
- Shimadzu Corporation
- Hologic, Inc.
- Fujifilm Holdings Corporation
- Carestream Health
- Samsung Medison
- Mindray Medical International
- Varian Medical Systems
- Ziehm Imaging GmbH
- Konica Minolta Healthcare Americas, Inc.
- United Imaging Healthcare Co., Ltd.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD 14.1 Billion |
|
Forecasted Value (2030) |
USD 20.6 Billion |
|
CAGR (2025 – 2030) |
6.6% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Global Interventional Imaging Market by Type (X-ray Systems, Ultrasound Systems, CT Scanners, MRI Systems, Fluoroscopy Systems), by Component (Hardware, Software, Services), by Application (Cardiology, Neurology, Orthopedics, Oncology), by End-Use Industry (Hospitals, Ambulatory Surgery Centers), and by Region |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems Corporation, Hitachi Medical Systems, Shimadzu Corporation, Fujifilm Holdings Corporation, Carestream Health, Samsung Medison, Mindray Medical International, Varian Medical Systems, Ziehm Imaging GmbH, United Imaging Healthcare Co., Ltd. |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Interventional Imaging Market, by Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. X-ray Systems |
|
4.2. Ultrasound Systems |
|
4.3. CT Scanners |
|
4.4. MRI Systems |
|
4.5. Fluoroscopy Systems |
|
5. Interventional Imaging Market, by Component (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Hardware |
|
5.2. Software |
|
5.3. Services |
|
6. Interventional Imaging Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Cardiology |
|
6.2. Neurology |
|
6.3. Orthopedics |
|
6.4. Oncology |
|
6.5. Others |
|
7. Interventional Imaging Market, by End-Use Industry (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Hospitals |
|
7.2. Ambulatory Surgery Centers |
|
7.3. Others |
|
8. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
8.1. Regional Overview |
|
8.2. North America |
|
8.2.1. Regional Trends & Growth Drivers |
|
8.2.2. Barriers & Challenges |
|
8.2.3. Opportunities |
|
8.2.4. Factor Impact Analysis |
|
8.2.5. Technology Trends |
|
8.2.6. North America Interventional Imaging Market, by Type |
|
8.2.7. North America Interventional Imaging Market, by Component |
|
8.2.8. North America Interventional Imaging Market, by Application |
|
8.2.9. North America Interventional Imaging Market, by End-Use Industry |
|
8.2.10. By Country |
|
8.2.10.1. US |
|
8.2.10.1.1. US Interventional Imaging Market, by Type |
|
8.2.10.1.2. US Interventional Imaging Market, by Component |
|
8.2.10.1.3. US Interventional Imaging Market, by Application |
|
8.2.10.1.4. US Interventional Imaging Market, by End-Use Industry |
|
8.2.10.2. Canada |
|
8.2.10.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
8.3. Europe |
|
8.4. Asia-Pacific |
|
8.5. Latin America |
|
8.6. Middle East & Africa |
|
9. Competitive Landscape |
|
9.1. Overview of the Key Players |
|
9.2. Competitive Ecosystem |
|
9.2.1. Level of Fragmentation |
|
9.2.2. Market Consolidation |
|
9.2.3. Product Innovation |
|
9.3. Company Share Analysis |
|
9.4. Company Benchmarking Matrix |
|
9.4.1. Strategic Overview |
|
9.4.2. Product Innovations |
|
9.5. Start-up Ecosystem |
|
9.6. Strategic Competitive Insights/ Customer Imperatives |
|
9.7. ESG Matrix/ Sustainability Matrix |
|
9.8. Manufacturing Network |
|
9.8.1. Locations |
|
9.8.2. Supply Chain and Logistics |
|
9.8.3. Product Flexibility/Customization |
|
9.8.4. Digital Transformation and Connectivity |
|
9.8.5. Environmental and Regulatory Compliance |
|
9.9. Technology Readiness Level Matrix |
|
9.10. Technology Maturity Curve |
|
9.11. Buying Criteria |
|
10. Company Profiles |
|
10.1. Siemens Healthineers |
|
10.1.1. Company Overview |
|
10.1.2. Company Financials |
|
10.1.3. Product/Service Portfolio |
|
10.1.4. Recent Developments |
|
10.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
10.2. GE HealthCare |
|
10.3. Philips Healthcare |
|
10.4. Canon Medical Systems Corporation |
|
10.5. Hitachi Medical Systems |
|
10.6. Shimadzu Corporation |
|
10.7. Hologic, Inc. |
|
10.8. Fujifilm Holdings Corporation |
|
10.9. Carestream Health |
|
10.10. Samsung Medison |
|
10.11. Mindray Medical International |
|
10.12. Varian Medical Systems |
|
10.13. Ziehm Imaging GmbH |
|
10.14. Konica Minolta Healthcare Americas, Inc. |
|
10.15. United Imaging Healthcare Co., Ltd. |
|
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Interventional Imaging Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Interventional Imaging Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.jpg)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Interventional Imaging Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA